QNRX
Price:
$0.7698
Market Cap:
$3.06M
Quoin Pharmaceuticals, Ltd., a specialty pharmaceutical company, focuses on the development of therapeutic products for rare and orphan diseases. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome. It also develops QRX004 for the treatment dystrophic epidermolysis bullosa; and QRX006, a therapy to treat rare skin disease. The company is based in Ashburn, Virginia.[Read more]
Industry
Biotechnology
IPO Date
2016-08-01
Stock Exchange
NASDAQ
Ticker
QNRX
According to Quoin Pharmaceuticals, Ltd.’s latest financial reports and current stock price. The company's current PE Ratio is -0.15. This represents a change of -64.84% compared to the average of -0.43 of the last 4 quarters.
The mean historical PE Ratio of Quoin Pharmaceuticals, Ltd. over the last ten years is -1.64. The current -0.15 PE Ratio has changed 814.12% with respect to the historical average. Over the past ten years (40 quarters), QNRX's PE Ratio was at its highest in in the December 2016 quarter at 0. The PE Ratio was at its lowest in in the June 2020 quarter at -26.98.
Average
-1.64
Median
-0.59
Minimum
-14.71
Maximum
3.85
Discovering the peaks and valleys of Quoin Pharmaceuticals, Ltd. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 386.27%
Maximum Annual PE Ratio = 3.85
Minimum Annual Increase = -440.98%
Minimum Annual PE Ratio = -14.71
Year | PE Ratio | Change |
---|---|---|
2023 | -0.51 | -31.18% |
2022 | -0.74 | -12.37% |
2021 | -0.85 | -94.25% |
2020 | -14.71 | 386.27% |
2019 | -3.03 | -440.98% |
2018 | 0.89 | -76.97% |
2017 | 3.85 | 319.13% |
2016 | 0.92 | -255.24% |
The current PE Ratio of Quoin Pharmaceuticals, Ltd. (QNRX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-0.70
5-year avg
-3.97
10-year avg
-1.64
Quoin Pharmaceuticals, Ltd.’s PE Ratio is greater than Blue Water Vaccines, Inc. (-0.17), less than PaxMedica, Inc. Common Stock (-0.00), less than Revelation Biosciences, Inc. (-0.09), less than Hillstream BioPharma, Inc. (-0.00), greater than Virax Biolabs Group Limited (-1.34), greater than NeuroBo Pharmaceuticals, Inc. (-0.73), greater than Allarity Therapeutics, Inc. (-0.19), less than Kiromic BioPharma, Inc. (-0.14), less than Biodexa Pharmaceuticals Plc (-0.05), greater than Unicycive Therapeutics, Inc. (-0.46), greater than Cardio Diagnostics Holdings, Inc. (-0.75),
Company | PE Ratio | Market cap |
---|---|---|
-0.17 | $3.41M | |
-0.00 | $834.97K | |
-0.09 | $1.43M | |
-0.00 | $4.17M | |
-1.34 | $15.24M | |
-0.73 | $29.70M | |
-0.19 | $7.01M | |
-0.14 | $3.14M | |
-0.05 | $105.64K | |
-0.46 | $33.41M | |
-0.75 | $6.94M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Quoin Pharmaceuticals, Ltd. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Quoin Pharmaceuticals, Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Quoin Pharmaceuticals, Ltd.'s PE Ratio?
How is the PE Ratio calculated for Quoin Pharmaceuticals, Ltd. (QNRX)?
What is the highest PE Ratio for Quoin Pharmaceuticals, Ltd. (QNRX)?
What is the 3-year average PE Ratio for Quoin Pharmaceuticals, Ltd. (QNRX)?
What is the 5-year average PE Ratio for Quoin Pharmaceuticals, Ltd. (QNRX)?
How does the current PE Ratio for Quoin Pharmaceuticals, Ltd. (QNRX) compare to its historical average?